Topic: MODERNA
142 results were found.
U.S. cancels contract with Moderna for bird flu shot - May 30, 2025
U.S. awards Moderna $176 mln for vaccine development amid bird flu outbreak - July 5, 2024
Moderna Q4 revenue $2.8 billion - February 23, 2024
Moderna slips to $3.63 billion loss in Q3 - November 2, 2023
Taiwan to start nationwide rollout of Moderna XBB vaccine October 11 - October 4, 2023
Lonza to stop producing Moderna COVID-19 vaccine - September 20, 2023
Health Canada approves Moderna COVID-19 vaccine for Omicron, urges boosters - September 13, 2023
Moderna to give Immatics more than $1.7 billion - September 12, 2023
Moderna updated COVID-19 vaccine effective against BA.2.86 - September 7, 2023
Moderna files for European authorization of updated COVID vaccine - July 3, 2023
Taiwan: Academia Sinica and Moderna to cooperate on mRNA research - June 5, 2023
UK authorizes Moderna COVID vaccine for infants as young as 6 months - May 10, 2023
Moderna and Merck mRNA cancer vaccine cut risk of death or recurrence of most deadly skin cancer by 44% - April 17, 2023
Moderna CEO defends $130 COVID vaccine price in Senate hearing - March 23, 2023
Moderna plans to hire approximately 2,000 new employees in 2023 - March 11, 2023
Moderna enters R&D collaboration for mRNA gene-editing therapies - February 23, 2023
Health Canada authorizes Moderna's Omicron-targeting bivalent COVID-19 vaccine in children and adolescents - February 22, 2023
Moderna finalizes strategic partnership with UK government - December 22, 2022
Moderna Q3 profit plunged 69 percent - November 4, 2022
Switzerland to destroy 9 million expired Moderna COVID-19 jabs - October 20, 2022
Merck opts to jointly develop cancer vaccine with Moderna - October 13, 2022
Moderna gets EMA review for Omicron BA.4/BA.5 targeting booster shot for aged 12, above - September 28, 2022
Ukraine stops deliveries of AstraZeneca, Moderna coronavirus vaccines - September 20, 2022
Singapore grants interim approval for Moderna's bivalent COVID-19 booster vaccine - September 15, 2022
FDA authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 vaccines for use as booster dose - September 1, 2022
Moderna sues Pfizer and BioNTech over coronavirus vaccine - August 26, 2022
Commission and Moderna adapt delivery schedules for late summer and winter - August 10, 2022
Moderna Q2 net income $2.20 billion - August 4, 2022
Australia provisionally approves Moderna's COVID shot for children under 5 - July 19, 2022
Moderna COVID shot approved for children as young as six months in Canada - July 14, 2022
Moderna announces new clinical data on Omicron COVID booster candidate MRNA-1273.214 - June 23, 2022
Moderna to open vaccine research and manufacturing centre in UK - June 22, 2022
Moderna updated COVID-19 shot under rolling review in Europe - June 18, 2022
EU secures agreement with Moderna to adapt delivery schedules to Member States' needs - June 2, 2022
Takeda and Moderna to transfer marketing authorization for Spikevax COVID vaccine in Japan to Moderna - May 31, 2022
IAVI and Moderna launch first African clinical trial oF MRNA HIV vaccine development program - May 24, 2022
Moderna makes David Meline interim CFO - May 12, 2022
Moderna to build COVID-19 vaccine facility in Canada - April 30, 2022
Moderna files to expand conditional authorization for COVID-19 vaccine for kids 6 months to under 6 years in EU - April 30, 2022
UK approves Moderna COVID-19 vaccine for children aged 6-11 - April 15, 2022
FDA approves second booster of Pfizer, Moderna vaccines for 50 and over - March 29, 2022
Moderna inks supply agreement with Switzerland for additional 7 million doses of COVID booster vaccine - March 21, 2022
Pfizer, Moderna seek FDA's authorization for second COVID booster shots - March 19, 2022
Canada authorizes Moderna Spikevax COVID-19 vaccine for children 6 to 11 - March 18, 2022
Moderna to build mRNA manufacturing facility in Kenya - March 8, 2022
EMA gives green light to Moderna vaccine for 6- to 11-year-olds - March 4, 2022
Moderna to establish enterprise solutions hub in Metro Atlanta, Georgia, create more than 150 new jobs - March 4, 2022
Moderna signs distribution deal in Latin America for COVID-19 vaccine - February 23, 2022
U.S. grants full approval to Moderna's COVID vaccine in adults - February 1, 2022
Chile to purchase 2 million Moderna COVID-19 vaccine doses - January 25, 2022
Moderna plans combined COVID-19, flu booster shot - January 18, 2022
Moderna signs COVID-19 vaccine deals worth $18.5 billion - January 11, 2022
Switzerland to purchase seven million additional doses of Moderna's COVID-19 booster - December 28, 2021
Moderna booster increases antibodies against Omicron - December 21, 2021
Increase in manufacturing capacity for COVID-19 vaccines from Janssen, Moderna and Pfizer - December 17, 2021
Moderna to produce mRNA vaccine in Australia - December 16, 2021
EU agrees with Moderna to rush COVID-19 vaccine supplies to Germany - December 16, 2021
Japan gives fast track approval to Moderna's COVID vaccine as booster - December 16, 2021
UK to buy 114 million additional Pfizer BioNTech and Moderna doses for 2022 and 2023 - December 2, 2021
COVID-19 vaccine for children aged 6 to 11: Moderna submits application for indication extension in Switzerland - November 18, 2021
Canada: Moderna seeking authorization of Spikevax COVID-19 vaccine in children 6-11 years old - November 17, 2021
French health authority advises against Moderna COVID-19 vaccine for under 30s - November 9, 2021
Moderna Q3 comes from loss to profit - November 4, 2021
Moderna vaccines made by Samsung Biologics to be available in South Korea this week - October 26, 2021
FDA recommends Moderna's COVID-19 vaccine booster for at-risk adults - October 16, 2021
COVAX exercises option to purchase 176.5 million additional doses of Moderna COVID-19 vaccine - October 13, 2021
Moderna to build mRNA facility in Africa to make up to 500 million doses per year - October 8, 2021
Finland pauses use of Moderna COVID-19 vaccine in young men - October 7, 2021
Sweden to give 12-15 year olds Pfizer vaccine, rejects Moderna - October 5, 2021
Canada data: Heart inflammation rates higher after Moderna COVID-19 shot than Pfizer vaccine - October 2, 2021
Ukraine developing COVID-19 vaccine similar to Pfizer or Moderna - October 1, 2021
Takeda says human error caused contamination of Moderna vaccines - October 1, 2021
Moderna to supply 20 million doses of COVID-19 vaccine to Peru - September 25, 2021
Moderna: Health Canada approves COVID-19 vaccine - September 17, 2021
Moderna working on combination COVID-19 vaccine booster and flu shot - September 10, 2021
Resilience to manufacture mRNA for Moderna’s COVID-19 vaccine - September 9, 2021
Moderna to recall COVID-19 doses in Japan after stainless steel contaminants found - September 2, 2021
Okinawa finds contaminants in Moderna COVID-19 vaccines - August 29, 2021
Two die in Japan after shots from suspended Moderna vaccines - August 28, 2021
Japan suspends use of 1.63 mln Moderna vaccine doses over contamination - August 26, 2021
Rovi says possible Moderna vaccine contamination under investigation - August 26, 2021
Increase in vaccine manufacturing capacity for COVID-19 vaccines from BioNTech / Pfizer and Moderna - August 25, 2021
UK approves Moderna vaccine for 12-17-year-olds - August 18, 2021
Canada negotiates additional agreement with Moderna for vaccine supply beyond 2021 - August 16, 2021
Moderna to start local production of COVID-19 mRNA vaccine in Canada - August 11, 2021
Australia gives conditional green light to Moderna COVID-19 vaccine - August 9, 2021
South Korea apologises as Moderna halves August COVID-19 vaccine shipments - August 9, 2021
Moderna Q2 revenue jumps - August 6, 2021
Moderna COVID-19 vaccine showed 93% efficacy remaining durable through six months - August 6, 2021
Italy authorizes Moderna COVID-19 vaccine for teens - July 29, 2021
Moderna announces new supply agreement with Taiwan - July 23, 2021
Moderna to supply 20 mln doses of COVID-19 vaccine to Argentina - July 13, 2021
Saudi Arabia approves Moderna vaccine - July 10, 2021
Indonesia approves Moderna vaccine - July 3, 2021
India allows Moderna COVID-19 vaccine for emergency use - June 30, 2021
Moderna: Our COVID-19 vaccine protects from all variants - June 30, 2021
Pfizer and Moderna may provide lifetime protection against COVID-19 - June 29, 2021
EU to buy 150m additional doses of Moderna jabs - June 23, 2021
Danaher to buy Moderna supplier Aldevron for about $9.6 billion - June 17, 2021
Additional manufacturing capacity for Moderna COVID-19 vaccine - June 13, 2021
EMA evaluating use of Moderna COVID-19 vaccine in people aged 12 to 17 - June 9, 2021
Moderna files for authorization with Health Canada, Europe for its COVID-19 vaccine in adolescents - June 8, 2021
Lonza plans new production line to make Moderna COVID-19 vaccine ingredients - June 2, 2021
Moderna, Samsung Biologics sign agreement for fill-finish manufacturing of COVID-19 vaccine - May 23, 2021
Japan approves Moderna, AstraZeneca COVID-19 vaccines - May 21, 2021
Thailand rolls out Moderna jab - May 8, 2021
Switzerland secures Moderna vaccine for 2022, has enough for all for 2021 - May 7, 2021
Moderna Q1 revenue $1.9 billion - May 6, 2021
Philippines approves Moderna COVID-19 vaccine for emergency use - May 5, 2021
WHO adds Moderna COVID-19 vaccine to emergency use list - May 1, 2021
EMA approves increased COVID vaccine production from Pfizer, Moderna - April 25, 2021
England to start vaccinating people aged 45 or over, rolls out Moderna vaccine - April 14, 2021
Moderna gets nod to speed up virus vaccine output with bigger vials - April 2, 2021
Increase in manufacturing capacity for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna - March 27, 2021
Slovenia: Pfizer, Moderna optional offers refused due to delivery timeline - March 22, 2021
Moderna starts COVID-19 vaccine candidate testing on children - March 16, 2021
Moderna begins testing next-generation coronavirus vaccine - March 15, 2021
Moderna to supply 13m doses of COVID-19 vaccine to Philippines - March 8, 2021
Vietnam approves Moderna, Sputnik V vaccine for emergency use - February 27, 2021
Moderna Q4 revenues jumped from $60 million to $803 million - February 26, 2021
Pfizer and BioNTech test third dose of COVID-19 vaccine, Moderna made booster for new variants - February 25, 2021
EU to buy 300m more COVID-19 vaccine doses from Moderna - February 18, 2021
Moderna to supply COVID-19 vaccine to Taiwan and Colombia - February 10, 2021
French labs to start producing Moderna, Pfizer COVID-19 vaccines - February 3, 2021
WHO approves use of Moderna vaccine - January 28, 2021
Moderna vaccine works against UK COVID-19 variant, South Africa variant must be improved - January 25, 2021
Moderna appoints José M. Vega as chief safety officer - January 12, 2021
UK regulators approve Moderna vaccine, Mayor of London declares major incident - January 8, 2021
EMA recommends COVID-19 Vaccine Moderna for authorisation in EU - January 6, 2021
Canada approves Moderna coronavirus vaccine - December 24, 2020
U.S. authorizes Moderna's coronavirus vaccine for emergency use - December 19, 2020
Roche partners with Moderna to include antibody test in coronavirus vaccine trials - December 9, 2020
Russia's Sputnik V coronavirus vaccine to be priced much lower than Pfizer’s and Moderna’s - November 23, 2020
UK government secures 5 million doses of Moderna vaccine - November 17, 2020
Moderna says its coronavirus vaccine candidate is stable in standard home refrigerator - November 16, 2020
Moderna gets further $472 million U.S. for coronavirus vaccine development - July 26, 2020
Moderna coronavirus vaccine enters final stage trial this month - July 15, 2020
Moderna to begin phase-3 coronavirus vaccine trial in July - June 12, 2020
Moderna revenue $8.4 million - May 8, 2020
Moderna appoints Annie Seibold Drapeau as CHRO - October 7, 2016
Moderna appoints Michael Watson as president of Valera - April 6, 2016
Moderna appoints former head of Sanofi global oncology as CMO - March 17, 2015